AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT BETWEEN Ocean Biomedical, Inc. AND WHITE LION CAPITAL LLCCommon Stock Purchase Agreement • October 6th, 2023 • Ocean Biomedical, Inc. • Pharmaceutical preparations
THIS AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT (this “Amendment”), effective October 4, 2023 (the “Amendment Effective Date”), is by and between Ocean Biomedical, Inc., f/k/a Aesther Healthcare Acquisition Corp. (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”) and amends the Common Stock Purchase Agreement between the Company and Investor dated September 7, 2022 (the “Agreement”). All capitalized terms used but not defined herein shall have the respective meanings ascribed to them in the Agreement.
